Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.5790
+0.0026 (0.45%)
At close: Feb 13, 2026, 4:00 PM EST
0.6150
+0.0360 (6.22%)
After-hours: Feb 13, 2026, 7:58 PM EST
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.05 million as of February 13, 2026. Its market cap has decreased by -39.22% in one year.
Market Cap
6.05M
Enterprise Value
-4.90M
1-Year Change
-39.22%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.05M, an increase of 21.70%. That is a compound annual growth rate of 1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 6.05M | -13.53% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 6.70M |
| Theriva Biologics | 6.49M |
| Immuron | 6.44M |
| Creative Medical Technology Holdings | 6.40M |
| Mustang Bio | 6.38M |
| Aptorum Group | 6.37M |
| Moolec Science | 6.27M |
| Alzamend Neuro | 6.20M |